Minimally Invasive Surgery Market by Product (Robotics, Imaging, Instrument (Handheld, inflation, Guiding, electrosurgery, endoscopy)), Application (CVD, thoracic, neuro, ENT, OB/GYN, orthopedic), Enduser - Global Forecast to 2029
The global minimally invasive surgery market is projected to reach USD 74.6 billion by 2029 from USD 34.0 billion in 2024, growing at a CAGR of 17.0% during the forecast period. The projected surge in market growth for minimally invasive surgery is underpinned by a confluence of advantages. Minimally invasive surgery are driven by an aging population, rising adoption of MIS over open surgeries, and an increasing numbers of hospitals with the increase in the number of surgical procedures. Furthermore, the increasing incidences of chronic disorders with improved efficacy for early diagnosis through imaging and visualization systems and treatment amplifies the demand for advanced modalities, with minimally invasive surgery. These factors are poised to create the phase of robust expansion within the market, consequently shaping the minimally invasive surgerry adoption in the coming forecasting years.
“Cardio-thoracic surgery segment to register largest market share in 2023-2029.”
Based on the application, the minimally invasive surgery market is segmented into cardiothoracic, vascular urology, neurological surgeries, ENT & Respiratory surgery, Cosmetic surgery, Gastrointestinal & Abdominal surgery, Gynecological surgery, Orthopedic, Oncology, Dental and other surgery. The cardio-thoracic surgery segment registered the largest market share over the forecast period of 2023-2029. The growth of this segment is due to the continuous innovation in surgical techniques, instruments, and imaging technology enhances the feasibility and safety of minimally invasive approaches in cardio-thoracic surgery. As medical practitioners gain proficiency in MIS techniques, they demonstrate greater confidence in employing these methods for complex cardio-thoracic procedures. Moreover, evolving healthcare policies and reimbursement structures that promote cost-effective and efficient treatment pathways further incentivize the integration of MIS into cardio-thoracic surgery practices.
“Hospitals, Clinics & Ablation centers segment held the largest share of minimally invasive surgery market in 2023, by End-user.”
Based on the end-user, the minimally invasive surgery market is segmented into Hospitals, clinics & ablations centers, Ambulatory surgical centers and orthopedic, emergency and trauma centers. In 2023, the hospitals, clinics & ablation centers segment accounted for the largest share of the global minimally invasive surgery market. The growth of this segment is being propelled by factors including a significant portion of less invasive surgeries, ranging from routine procedures to complex interventions, adoption of advanced MIS technologies, and shaping trends with their clinical practices.
“Asia Pacific to register significant growth rate in the market during the forecast period.”
For the forecasting period 2024-2024, the APAC region is expected to register a significant growth rate during the forecast period. Asia Pacific comprises India, China, Japan, Australia, South Korea, and RoAPAC. The Asia-Pacific (APAC) region has witnessed a significant increase in the market growth rate for minimally invasive surgery. There are several drivers that contributed to this growth:
The Asia Pacific market is experiencing growth due to rising investments by government organisations in emerging countries aimed at enhancing healthcare infrastructure. Additionally, the market is benefiting from the rise in independent orthopedic, emergency and trauma centers, a substantial aging patient population, and strategic initiatives by industry players to expand their offerings of MIS products in the Asia Pacific region.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
The report will help the new entrants/ market leaders/smaller firms in this market with investment evaluation viability within the minimally invasive surgery market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing application, end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, challenges, growth catalysts and prospects, thereby empowering strategic decision-making with astute discernment.
The report provides insights on the following pointers:
“Cardio-thoracic surgery segment to register largest market share in 2023-2029.”
Based on the application, the minimally invasive surgery market is segmented into cardiothoracic, vascular urology, neurological surgeries, ENT & Respiratory surgery, Cosmetic surgery, Gastrointestinal & Abdominal surgery, Gynecological surgery, Orthopedic, Oncology, Dental and other surgery. The cardio-thoracic surgery segment registered the largest market share over the forecast period of 2023-2029. The growth of this segment is due to the continuous innovation in surgical techniques, instruments, and imaging technology enhances the feasibility and safety of minimally invasive approaches in cardio-thoracic surgery. As medical practitioners gain proficiency in MIS techniques, they demonstrate greater confidence in employing these methods for complex cardio-thoracic procedures. Moreover, evolving healthcare policies and reimbursement structures that promote cost-effective and efficient treatment pathways further incentivize the integration of MIS into cardio-thoracic surgery practices.
“Hospitals, Clinics & Ablation centers segment held the largest share of minimally invasive surgery market in 2023, by End-user.”
Based on the end-user, the minimally invasive surgery market is segmented into Hospitals, clinics & ablations centers, Ambulatory surgical centers and orthopedic, emergency and trauma centers. In 2023, the hospitals, clinics & ablation centers segment accounted for the largest share of the global minimally invasive surgery market. The growth of this segment is being propelled by factors including a significant portion of less invasive surgeries, ranging from routine procedures to complex interventions, adoption of advanced MIS technologies, and shaping trends with their clinical practices.
“Asia Pacific to register significant growth rate in the market during the forecast period.”
For the forecasting period 2024-2024, the APAC region is expected to register a significant growth rate during the forecast period. Asia Pacific comprises India, China, Japan, Australia, South Korea, and RoAPAC. The Asia-Pacific (APAC) region has witnessed a significant increase in the market growth rate for minimally invasive surgery. There are several drivers that contributed to this growth:
The Asia Pacific market is experiencing growth due to rising investments by government organisations in emerging countries aimed at enhancing healthcare infrastructure. Additionally, the market is benefiting from the rise in independent orthopedic, emergency and trauma centers, a substantial aging patient population, and strategic initiatives by industry players to expand their offerings of MIS products in the Asia Pacific region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%
- By Designation: C-level-- 27%, Director-level–18%, and Others–55%
- By Region: North America–50%, Europe-20%, Asia Pacific–15%, Latin America–10%, and the Middle East & Africa–5%
Research Coverage
- The report studies the minimally invasive surgery market based on products, application, end user, and region.
- The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
- The report studies micro markets with respect to their growth trends, prospects, and contributions to the global minimally invasive surgery market
- The report forecasts the revenue of market segments with respect to five major regions.
The report will help the new entrants/ market leaders/smaller firms in this market with investment evaluation viability within the minimally invasive surgery market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing application, end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, challenges, growth catalysts and prospects, thereby empowering strategic decision-making with astute discernment.
The report provides insights on the following pointers:
- Analysis of key drivers (increasing prevalence of chronic disorder diseases, Increasing number of hospitals coupled with increasing number of surgical procedures worldwide, adoption of MIS over open surgeries), restraints (changing regulatory landscape in medical device industry and high cost of robotic systems), opportunities (increasing adoption of advanced robotics in ASCs, Emerging markets offers high-growth opportunities), and challenges (High degree of market consolidation) influencing the growth of the minimally invasive surgery market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the minimally invasive surgery market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the minimally invasive surgery market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the minimally invasive surgery market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Medtronic (Ireland), Johnson & Johnson (US), Stryker Corporation (US), Boston Scientific Corporation (US), among others.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
2.2.2.1 Primary sources
2.2.2.2 Key industry insights
2.2.2.3 Breakdown of primaries
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
FIGURE 4 MINIMALLY INVASIVE SURGERY MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
2.3.1.2 Approach 2: Customer-based market estimation
FIGURE 5 MINIMALLY INVASIVE SURGERY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.3.1.3 Approach 3: Top-down approach
2.3.1.4 Approach 4: Primary interviews
FIGURE 6 TOP-DOWN APPROACH
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH LIMITATIONS
2.6 STUDY ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT ANALYSIS
2.8 GROWTH RATE ASSUMPTIONS
2.9 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 8 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 9 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 10 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 11 GEOGRAPHIC SNAPSHOT OF MINIMALLY INVASIVE SURGERY MARKET
4 PREMIUM INSIGHTS
4.1 MINIMALLY INVASIVE SURGERY MARKET OVERVIEW
FIGURE 12 INCREASING ADOPTION OF MIS OVER OPEN SURGERIES TO DRIVE MARKET DURING FORECAST PERIOD
4.2 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
FIGURE 13 NORTH AMERICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.3 MINIMALLY INVASIVE SURGERY MARKET, BY REGION AND END USER, 2023 (USD MILLION)
FIGURE 14 HOSPITALS, CLINICS, AND ABLATION CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
4.4 GEOGRAPHIC SNAPSHOT OF MINIMALLY INVASIVE SURGERY MARKET
FIGURE 15 FRANCE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
FIGURE 16 MINIMALLY INVASIVE SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 Increasing number of hospitals and surgeries
5.1.1.2 Increasing adoption of MIS over open surgeries
5.1.1.3 Advantages of robot-assisted surgery & training in rehabilitation therapy
5.1.1.4 Technological advancements
TABLE 2 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL ROBOTS
5.1.2 RESTRAINTS
5.1.2.1 Changing regulatory landscape in medical devices
5.1.2.2 High cost of robotic systems
5.1.3 OPPORTUNITIES
5.1.3.1 Emerging markets
5.1.3.2 Increasing adoption of advanced robotics in ASCs
5.1.4 CHALLENGES
5.1.4.1 High degree of market consolidation
5.2 PORTER’S FIVE FORCES ANALYSIS
TABLE 3 MINIMALLY INVASIVE SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 THREAT OF SUBSTITUTES
5.2.3 BARGAINING POWER OF SUPPLIERS
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 DEGREE OF COMPETITION
5.3 TARIFF AND REGULATORY LANDSCAPE
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4 KEY REGULATORY GUIDELINES
5.4.1 US
TABLE 9 US FDA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.2 EUROPE
5.4.3 JAPAN
5.5 ECOSYSTEM ANALYSIS
FIGURE 17 MINIMALLY INVASIVE SURGERY MARKET: ECOSYSTEM
FIGURE 18 MINIMALLY INVASIVE SURGERY MARKET: KEY PLAYERS
5.6 TECHNOLOGY ANALYSIS
5.6.1 KEY TECHNOLOGIES
5.6.1.1 Laparoscopy
5.6.1.2 Ablation
5.6.1.3 Electrosurgery
5.6.1.4 Powered surgical products
5.6.2 COMPLIMENTARY TECHNOLOGIES
5.6.2.1 Robotic surgery
5.6.2.2 Digital solutions (AI, IoT)
5.6.2.3 Medical/Surgical imaging
5.6.3 ADJACENT TECHNOLOGIES
5.6.3.1 Endoscopes
5.6.3.2 Surgical implants
5.7 VALUE CHAIN ANALYSIS
5.7.1 RESEARCH & DEVELOPMENT
5.7.2 PROCUREMENT & PRODUCT DEVELOPMENT
5.7.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
FIGURE 19 MINIMALLY INVASIVE SURGERY MARKET: VALUE CHAIN ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
5.8.1 PROMINENT COMPANIES
5.8.2 SMALL & MEDIUM-SIZED COMPANIES
5.8.3 END USERS
FIGURE 20 MINIMALLY INVASIVE SURGERY MARKET: SUPPLY CHAIN ANALYSIS
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
5.9.2 KEY BUYING CRITERIA
5.10 REIMBURSEMENT SCENARIO
TABLE 11 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
5.11 PRICING ANALYSIS
FIGURE 21 AVERAGE SELLING PRICE OF MINIMALLY INVASIVE PRODUCTS, BY PRODUCT (FY 2021-2023)
FIGURE 22 AVERAGE SELLING PRICE TREND, BY REGION
5.12 PATENT ANALYSIS
FIGURE 23 PATENT DETAILS FOR MINIMALLY INVASIVE SURGERY DEVICES (JANUARY 2013–DECEMBER 2023)
5.13 TRADE ANALYSIS
TABLE 12 IMPORT DATA FOR MIS MARKET (HS CODE 9021), BY COUNTRY, 2018–2022 (USD THOUSAND)
TABLE 13 EXPORT DATA FOR MIS MARKET (HS CODE 3822), BY COUNTRY, 2018–2022 (USD THOUSAND)
5.14 CASE STUDIES
TABLE 14 CASE STUDY 1: ROLE OF MINIMALLY INVASIVE ROBOT-ASSISTED SURGERY IN UROLOGY
TABLE 15 CASE STUDY 2: PIONEERING ROBOT-ASSISTED LATERAL LUMBAR INTERBODY FUSION (LLIF) WITH EXCELSIUSGPS
5.15 KEY CONFERENCES AND EVENTS, 2023–2024
TABLE 16 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2023–2024
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 24 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
5.17 MINIMALLY INVASIVE SURGERY MARKET: RECESSION IMPACT
5.18 UNMET CUSTOMER NEEDS IN MINIMALLY INVASIVE SURGERY MARKET
5.19 INVESTMENT SCENARIO
FIGURE 25 NUMBER OF INVESTOR DEALS IN MINIMALLY INVASIVE SURGERY MARKET, BY KEY PLAYER, 2018–2022
FIGURE 26 VALUE OF INVESTOR DEALS IN MINIMALLY INVASIVE SURGERY MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
6 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 17 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
6.2 SURGICAL DEVICES
TABLE 18 SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 19 SURGICAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.1 HANDHELD INSTRUMENTS
TABLE 20 HANDHELD INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.1.1 Tubular retractors
6.2.1.1.1 Minimized tissue trauma and better outcomes to support adoption
6.2.1.2 Dilators
6.2.1.2.1 Safety and efficient surgical site access to support adoption
6.2.1.3 Suturing instruments
6.2.1.3.1 Rising procedural volume and growing demand for MIS to drive market
6.2.1.4 Probes
6.2.1.4.1 Advancements in instrumentation and product launches to drive market
6.2.1.5 Laser fiber devices
6.2.1.5.1 Growing demand in urology, gastroenterology, and other specialties to support market growth
6.2.2 GUIDING DEVICES
TABLE 21 GUIDING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.2.1 Guiding catheters
6.2.2.1.1 Focus on functional and design improvements to drive demand
6.2.2.2 Guidewires
6.2.2.2.1 Rising PCTA and PTA procedural volumes to ensure demand growth
6.2.3 INFLATION SYSTEMS
TABLE 22 INFLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.3.1 Balloon catheters
6.2.3.1.1 Technological advancements in balloon systems to support growth
6.2.3.2 Balloon inflation systems
6.2.3.2.1 Growing adoption of MIS in coronary and peripheral disease treatment to drive market
6.2.4 LAPAROSCOPY DEVICES
TABLE 23 LAPAROSCOPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.4.1 Laparoscopes
6.2.4.1.1 Lower risk of laparoscopic procedures to drive demand
6.2.4.2 Trocars & cannulas
6.2.4.2.1 Need to ensure accurate placement to support growth
6.2.4.3 Graspers & dissectors
6.2.4.3.1 Benefits such as increased safety and better reach to drive adoption
6.3 IMAGING & VISUALIZATION SYSTEMS
TABLE 24 IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 25 IMAGING & VISUALIZATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.1 ULTRASOUND SYSTEMS
6.3.1.1 Ultrasound to hold largest share of imaging & visualization systems market
TABLE 26 ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.2 CT SCANNERS
6.3.2.1 Shift toward image-guided interventions and rising disease prevalence to drive market
TABLE 27 CT SCANNERS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.3 MRI SYSTEMS
6.3.3.1 Wide usage and technological advancements to support growth
TABLE 28 MRI SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.4 X-RAY SYSTEMS
6.3.4.1 Rising emphasis on digital X-ray systems to drive market
TABLE 29 X-RAY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.5 VISUALIZATION SYSTEMS
6.3.5.1 High levels of detail and better outcomes to drive demand
TABLE 30 VISUALIZATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4 ELECTROSURGICAL DEVICES
TABLE 31 ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 32 ELECTROSURGICAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4.1 ELECTROCAUTERY DEVICES
6.4.1.1 Increasing plastic surgeries to drive market
TABLE 33 ELECTROCAUTERY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4.2 ELECTROSURGICAL GENERATORS & ACCESSORIES
6.4.2.1 Growing use of disposables and reusable instruments to drive market
TABLE 34 ELECTROSURGICAL GENERATORS & ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.5 ENDOSCOPY DEVICES
TABLE 35 ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 36 ENDOSCOPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.5.1 RIGID ENDOSCOPES
6.5.1.1 Rigid endoscopes to hold largest market share
TABLE 37 RIGID ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.5.2 FLEXIBLE ENDOSCOPES
6.5.2.1 Rising incidence of cancer to drive demand
TABLE 38 FLEXIBLE ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.5.3 DIAGNOSTIC ENDOSCOPES
6.5.3.1 Role of diagnostic endoscopes to expand due to versatility and sophistication
TABLE 39 DIAGNOSTIC ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.6 MEDICAL ROBOTICS
TABLE 40 MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 41 MEDICAL ROBOTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.6.1 ROBOTIC SYSTEMS
6.6.1.1 Accuracy, efficiency, and ability to conduct highly complex procedures to support market growth
TABLE 42 ROB0TIC SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.6.2 ROBOTIC INSTRUMENTS
6.6.2.1 Rising demand for robotic surgical procedures to drive market
TABLE 43 ROB0TIC INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.6.3 ROBOTIC SOFTWARE & SERVICES
6.6.3.1 Need for basic training and expertise in robotic systems to drive market
TABLE 44 ROBOTIC SOFTWARE & SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
7 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 45 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
7.2 CARDIOTHORACIC SURGERY
7.2.1 GROWING BURDEN OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
TABLE 46 MINIMALLY INVASIVE SURGERY MARKET FOR CARDIOTHORACIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.3 VASCULAR SURGERY
7.3.1 BENEFITS SUCH AS PRECISE CUTS WITH LIMITED BLOOD LOSS IN VASCULAR SURGERY TO SUPPORT GROWTH
TABLE 47 MINIMALLY INVASIVE SURGERY MARKET FOR VASCULAR SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.4 NEUROLOGICAL SURGERY
7.4.1 INCREASING NUMBER OF PATIENTS SUFFERING FROM NEUROLOGICAL DISORDERS TO DRIVE SEGMENT GROWTH
TABLE 48 MINIMALLY INVASIVE SURGERY MARKET FOR NEUROLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.5 ENT & RESPIRATORY SURGERY
7.5.1 BENEFITS OF MIS IN HEAD AND NECK DISORDER TREATMENT TO DRIVE MARKET
TABLE 49 MINIMALLY INVASIVE SURGERY MARKET FOR ENT & RESPIRATORY SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.6 COSMETIC SURGERY
7.6.1 GROWING PREFERENCE FOR COSMETIC PROCEDURES TO DRIVE MARKET
TABLE 50 MINIMALLY INVASIVE SURGERY MARKET FOR COSMETIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.7 GASTROINTESTINAL & ABDOMINAL SURGERY
7.7.1 RISING COLORECTAL CANCER PREVALENCE TO SUPPORT DEMAND
TABLE 51 MINIMALLY INVASIVE SURGERY MARKET FOR GASTROINTESTINAL & ABDOMINAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.8 GYNECOLOGICAL SURGERY
7.8.1 GROWING NUMBER OF LAPAROSCOPIC HYSTERECTOMIES PERFORMED TO SUPPORT MARKET GROWTH
TABLE 52 MINIMALLY INVASIVE SURGERY MARKET FOR GYNECOLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.9 UROLOGICAL SURGERY
7.9.1 INCREASING PREVALENCE OF UROLOGIC CANCERS TO DRIVE ADOPTION OF MIS
TABLE 53 MINIMALLY INVASIVE SURGERY MARKET FOR UROLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.10 ORTHOPEDIC SURGERY
7.10.1 RISING GERIATRIC POPULATION AND INCREASE IN ORTHOPEDIC DISORDERS TO DRIVE MARKET
TABLE 54 MINIMALLY INVASIVE SURGERY MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.11 ONCOLOGICAL SURGERY
7.11.1 GROWING DEMAND FOR RADIOTHERAPY AND CHEMOTHERAPY TO AFFECT SEGMENT GROWTH
TABLE 55 MINIMALLY INVASIVE SURGERY MARKET FOR ONCOLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.12 DENTAL SURGERY
7.12.1 EMPHASIS ON PREVENTIVE DENTAL CARE TO SUPPORT MARKET GROWTH
TABLE 56 MINIMALLY INVASIVE SURGERY MARKET FOR DENTAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.13 OTHER SURGERIES
TABLE 57 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER SURGERIES, BY REGION, 2022–2029 (USD MILLION)
8 MINIMALLY INVASIVE SURGERY MARKET, BY END USER
8.1 INTRODUCTION
TABLE 58 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
8.2 HOSPITALS, CLINICS, AND ABLATION CENTERS
8.2.1 RISING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE MARKET
TABLE 59 MINIMALLY INVASIVE SURGERY MARKET FOR HOSPITALS, CLINICS AND ABLATION CENTERS, BY REGION, 2022–2029 (USD MILLION)
8.3 AMBULATORY SURGERY CENTERS
8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL GROWTH
TABLE 60 MINIMALLY INVASIVE SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION)
8.4 ORTHOPEDIC, EMERGENCY, AND TRAUMA CENTERS
8.4.1 RISING USE OF ROBOTIC-ASSISTED SURGICAL SYSTEMS IN ORTHOPEDICS, EMERGENCY, AND TRAUMA CARE TO SUPPORT GROWTH
TABLE 61 MINIMALLY INVASIVE SURGERY MARKET FOR ORTHOPEDIC, EMERGENCY, AND TRAUMA CENTERS, BY REGION, 2022–2029 (USD MILLION)
8.5 OTHER END USERS
TABLE 62 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
9 MINIMALLY INVASIVE SURGERY MARKET, BY REGION
9.1 INTRODUCTION
TABLE 63 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2022–2029 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 27 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT
TABLE 64 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 66 NORTH AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 67 NORTH AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 68 NORTH AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 69 NORTH AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 70 NORTH AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 71 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 72 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2.2 US
9.2.2.1 US to dominate North American market
TABLE 73 US: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 74 US: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 75 US: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 76 US: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 77 US: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 78 US: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Rising cancer and IBD incidence to drive market
TABLE 79 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 80 CANADA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 81 CANADA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 82 CANADA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 83 CANADA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 84 CANADA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
TABLE 85 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 87 EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 88 EUROPE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 89 EUROPE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 90 EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 91 EUROPE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 92 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 93 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Well-established healthcare system in Germany to boost usage of instruments
TABLE 94 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 95 GERMANY: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 96 GERMANY: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 97 GERMANY: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 98 GERMANY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 99 GERMANY: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Rising number of hip & knee surgeries to drive market
TABLE 100 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 101 FRANCE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 102 FRANCE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 103 FRANCE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 104 FRANCE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 105 FRANCE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.3.4 UK
9.3.4.1 High incidence of cancer in the UK to boost adoption of MIS instruments
TABLE 106 UK: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 107 UK: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 108 UK: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 109 UK: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 110 UK: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 111 UK: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Demand for MIS to positively affect market growth
TABLE 112 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 113 ITALY: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 114 ITALY: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 115 ITALY: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 116 ITALY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 117 ITALY: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Increasing incidence of CVD to boost adoption of MIS and drive market growth
TABLE 118 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 119 SPAIN: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 120 SPAIN: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 121 SPAIN: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 122 SPAIN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 123 SPAIN: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 124 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 125 REST OF EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 126 REST OF EUROPE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 127 REST OF EUROPE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 128 REST OF EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 129 REST OF EUROPE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 28 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT
TABLE 130 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 131 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 132 ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 133 ASIA PACIFIC: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 134 ASIA PACIFIC: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 135 ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 136 ASIA PACIFIC: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 137 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 138 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising geriatric population in Japan to increase prevalence of chronic conditions and support market growth
TABLE 139 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 140 JAPAN: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 141 JAPAN: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 142 JAPAN: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 143 JAPAN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 144 JAPAN: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Rising disease prevalence and infrastructural improvements to support market growth
TABLE 145 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 146 CHINA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 147 CHINA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 148 CHINA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 149 CHINA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 150 CHINA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Healthcare infrastructure improvements and increasing geriatric population to drive market
TABLE 151 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 152 INDIA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 153 INDIA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 154 INDIA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 155 INDIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 156 INDIA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.4.5 AUSTRALIA
9.4.5.1 Uneven distribution of specialists to hinder market growth
TABLE 157 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 158 AUSTRALIA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 159 AUSTRALIA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 160 AUSTRALIA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 161 AUSTRALIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 162 AUSTRALIA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.4.6 SOUTH KOREA
9.4.6.1 Growing medical tourism to favor demand for MIS
TABLE 163 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 164 SOUTH KOREA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 165 SOUTH KOREA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 166 SOUTH KOREA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 167 SOUTH KOREA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 168 SOUTH KOREA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 169 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 170 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 171 REST OF ASIA PACIFIC: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 172 REST OF ASIA PACIFIC: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 173 REST OF ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 174 REST OF ASIA PACIFIC: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 175 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 177 LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 178 LATIN AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 179 LATIN AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 180 LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 181 LATIN AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 182 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 183 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
9.5.2 BRAZIL
9.5.2.1 Favorable healthcare policies by government and private organizations to propel market growth
TABLE 184 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 185 BRAZIL: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 186 BRAZIL: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 187 BRAZIL: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 188 BRAZIL: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 189 BRAZIL: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.5.3 MEXICO
9.5.3.1 Rising adoption of robotics in cosmetic surgeries to drive market
TABLE 190 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 191 MEXICO: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 192 MEXICO: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 193 MEXICO: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 194 MEXICO: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 195 MEXICO: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
TABLE 196 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 197 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 198 REST OF LATIN AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 199 REST OF LATIN AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 200 REST OF LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 201 REST OF LATIN AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 202 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 203 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 204 MIDDLE EAST & AFRICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 205 MIDDLE EAST & AFRICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 206 MIDDLE EAST & AFRICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 207 MIDDLE EAST & AFRICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 208 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 209 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
9.6.2 GCC COUNTRIES
9.6.2.1 Growing demand for minimally invasive procedures
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 29 OVERVIEW OF STRATEGIES ADOPTED BY MINIMALLY INVASIVE SURGERY PLAYERS
10.3 REVENUE SHARE ANALYSIS
FIGURE 30 REVENUE SHARE ANALYSIS FOR KEY PLAYERS, 2018–2022 (USD MILLION)
10.4 MARKET SHARE ANALYSIS
10.4.1 GLOBAL SURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 31 SURGICAL DEVICES MARKET SHARE ANALYSIS, 2022
10.4.2 GLOBAL IMAGING & VISUALIZATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 32 IMAGING & VISUALIZATION SYSTEMS MARKET SHARE ANALYSIS, 2022
10.4.3 GLOBAL ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 33 ENDOSCOPY DEVICES MARKET SHARE ANALYSIS, 2022
10.4.4 GLOBAL ELECTROSURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 34 ELECTROSURGICAL DEVICES MARKET SHARE ANALYSIS, 2022
10.4.5 GLOBAL MEDICAL ROBOTICS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 35 MEDICAL ROBOTICS MARKET SHARE ANALYSIS, 2022
FIGURE 36 MINIMALLY INVASIVE SURGERY MARKET SHARE, BY PLAYER (2023)
TABLE 210 MINIMALLY INVASIVE SURGERY MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION MATRIX (KEY PLAYERS)
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 37 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
10.5.5 COMPANY FOOTPRINT
FIGURE 38 COMPANY FOOTPRINT (15 COMPANIES)
TABLE 211 PRODUCT FOOTPRINT (15 COMPANIES)
TABLE 212 REGIONAL FOOTPRINT (15 COMPANIES)
TABLE 213 APPLICATION FOOTPRINT (15 COMPANIES)
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 39 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022
10.6.5 COMPANY BENCHMARKING
TABLE 214 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY EMERGING PLAYERS/STARTUPS
TABLE 215 MINIMALLY INVASIVE SURGERY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 216 MINIMALLY INVASIVE SURGERY MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2021—OCTOBER 2023)
10.7.2 DEALS
TABLE 217 MINIMALLY INVASIVE SURGERY MARKET: DEALS (JANUARY 2021—OCTOBER 2023)
10.8 COMPANY VALUATION AND FINANCIAL METRICS
FIGURE 40 EV/EBITDA OF KEY VENDORS
FIGURE 41 5-YEAR STOCK BETA OF KEY VENDORS
10.9 PRODUCT/BRAND COMPARISON
FIGURE 42 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL (2023)
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 MEDTRONIC PLC
TABLE 218 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
TABLE 219 MEDTRONIC PLC: PRODUCTS OFFERED
TABLE 220 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 221 MEDTRONIC PLC: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.2 JOHNSON & JOHNSON MEDTECH
TABLE 222 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW
FIGURE 44 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2022)
TABLE 223 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED
TABLE 224 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 225 JOHNSON & JOHNSON: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.3 STRYKER CORPORATION
TABLE 226 STRYKER CORPORATION: COMPANY OVERVIEW
FIGURE 45 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 227 STRYKER CORPORATION: PRODUCTS OFFERED
TABLE 228 STRYKER CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 229 STRYKER CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.4 BOSTON SCIENTIFIC CORPORATION
TABLE 230 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 231 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 232 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 233 BOSTON SCIENTIFIC CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.5 ABBOTT LABORATORIES
TABLE 234 ABBOTT LABORATORIES: COMPANY OVERVIEW
FIGURE 47 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
TABLE 235 ABBOTT LABORATORIES: PRODUCTS OFFERED
TABLE 236 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
11.1.6 ZIMMER BIOMET HOLDINGS, INC.
TABLE 237 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW
FIGURE 48 ZIMMER BIOMET HOLDINGS: COMPANY SNAPSHOT (2022)
TABLE 238 ZIMMER BIOMET HOLDINGS: PRODUCTS OFFERED
TABLE 239 ZIMMER BIOMET HOLDINGS: PRODUCT APPROVALS (JANUARY 2020–DECEMBER 2023)
11.1.7 B. BRAUN MELSUNGEN AG
TABLE 240 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
FIGURE 49 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
TABLE 241 B. BRAUN MELSUNGEN: PRODUCTS OFFERED
11.1.8 NUVASIVE, INC.
TABLE 242 NUVASIVE, INC: COMPANY OVERVIEW
FIGURE 50 NUVASIVE, INC: COMPANY SNAPSHOT (2022)
TABLE 243 NUVASIVE INC.: PRODUCTS OFFERED
TABLE 244 NUVASIVE, INC: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 245 NUVASIVE INC.: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.9 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 246 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW
FIGURE 51 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 247 INTEGRA LIFESCIENCES HOLDING CORPORATION: PRODUCTS OFFERED
11.1.10 ATEC SPINE
TABLE 248 ATEC SPINE: COMPANY OVERVIEW
FIGURE 52 ATEC SPINE: COMPANY SNAPSHOT (2022)
TABLE 249 ATEC SPINE: PRODUCTS OFFERED
11.1.11 SIEMENS HEALTHINEERS AG
TABLE 250 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
FIGURE 53 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
TABLE 251 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
TABLE 252 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 253 SIEMENS HEALTHINEERS AG: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 254 SIEMENS HEALTHINEERS AG: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
11.1.12 COOK MEDICAL
TABLE 255 COOK MEDICAL: COMPANY OVERVIEW
TABLE 256 COOK MEDICAL: PRODUCTS OFFERED
11.1.13 FUJIFILM CORPORATION
TABLE 257 FUJIFILM CORPORATION: COMPANY OVERVIEW
FIGURE 54 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 258 FUJIFILM CORPORATION: PRODUCTS OFFERED
TABLE 259 FUJIFILM CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 260 FUJIFILM CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 261 FUJIFILM CORPORATION: EXPANSION (JANUARY 2020–DECEMBER 2023)
TABLE 262 FUJIFILM CORPORATION: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
11.1.14 BECTON, DICKINSON AND COMPANY
TABLE 263 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
TABLE 264 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 265 BECTON, DICKINSON AND COMPANY: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 266 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
11.1.15 PHILIPS HEALTHCARE
TABLE 267 PHILIPS HEALTHCARE: COMPANY OVERVIEW
FIGURE 56 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)
TABLE 268 PHILIPS HEALTHCARE: PRODUCTS OFFERED
TABLE 269 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 270 PHILIPS HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.16 GLOBUS MEDICAL, INC.
TABLE 271 GLOBUS MEDICAL, INC.: COMPANY OVERVIEW
FIGURE 57 GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT (2022)
TABLE 272 GLOBUS MEDICAL: PRODUCTS OFFERED
TABLE 273 GLOBUS MEDICAL: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
11.2 OTHER PLAYERS
11.2.1 INTUITIVE SURGICAL INC.
TABLE 274 INTUITIVE SURGICAL INC.: COMPANY OVERVIEW
FIGURE 58 INTUITIVE SURGICAL INC.: COMPANY SNAPSHOT (2022)
TABLE 275 INTUITIVE SURGICAL INC.: PRODUCTS OFFERED
TABLE 276 INTUITIVE SURGICAL, INC.: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 277 INTUITIVE SURGICAL, INC.: DEALS (JANUARY 2020–DECEMBER 2023)
11.2.2 KARL STORZ
TABLE 278 KARL STORZ: COMPANY OVERVIEW (2022)
TABLE 279 KARL STORZ: PRODUCTS OFFERED
TABLE 280 KARL STORZ: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 281 KARL STORZ: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
11.2.3 EDWARDS LIFESCIENCES CORPORATION
TABLE 282 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
FIGURE 59 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 283 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
11.2.4 SMITH+NEPHEW
TABLE 284 SMITH+NEPHEW: COMPANY OVERVIEW
FIGURE 60 SMITH+NEPHEW: COMPANY SNAPSHOT (2022)
TABLE 285 SMITH+NEPHEW: PRODUCTS OFFERED
TABLE 286 SMITH+NEPHEW: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 287 SMITH+ NEPHEW: DEALS (JANUARY 2020–DECEMBER 2023)
11.2.5 GE HEALTHCARE
TABLE 288 GE HEALTHCARE: COMPANY OVERVIEW
FIGURE 61 GENERAL ELECTRIC: COMPANY SNAPSHOT (2022)
TABLE 289 GE HEALTHCARE: PRODUCTS OFFERED
TABLE 290 GE HEALTHCARE: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 291 GE HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 292 NIPRO CORPORATION: COMPANY OVERVIEW
FIGURE 62 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 293 NIPRO CORPORATION: PRODUCTS OFFERED
TABLE 294 NIPRO CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
11.2.7 GETINGE AB
TABLE 295 GETINGE AB: COMPANY OVERVIEW
FIGURE 63 GETINGE AB: COMPANY SNAPSHOT (2022)
TABLE 296 GETINGE AB: PRODUCTS OFFERED
11.2.8 CONMED CORPORATION
TABLE 297 CONMED CORPORATION: COMPANY OVERVIEW
FIGURE 64 CONMED CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 298 CONMED CORPORATION: PRODUCTS OFFERED
TABLE 299 CONMED CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
11.2.9 TELEFLEX INCORPORATED
TABLE 300 TELEFLEX INCORPORATED: COMPANY OVERVIEW
FIGURE 65 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
TABLE 301 TELEFLEX INCORPORATED: PRODUCTS OFFERED
TABLE 302 TELEFLEX INCORPORATION: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
11.2.10 ACCURAY
TABLE 303 ACCURAY: COMPANY OVERVIEW
FIGURE 66 ACCURAY: COMPANY SNAPSHOT (2022)
TABLE 304 ACCURAY: PRODUCTS OFFERED
TABLE 305 ACCURAY: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 306 ACCURAY: DEALS (JANUARY 2020–DECEMBER 2023)
11.2.11 OLYMPUS CORPORATION
TABLE 307 OLYMPUS CORPORATION: COMPANY OVERVIEW
FIGURE 67 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 308 OLYMPUS CORPORATION: PRODUCTS OFFERED
TABLE 309 OLYMPUS CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 310 OLYMPUS CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2.12 MASIMO
11.2.13 COOPERSURGICAL INC.
11.2.14 APPLIED MEDICAL
11.2.15 RICHARD WOLF
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
2.2.2.1 Primary sources
2.2.2.2 Key industry insights
2.2.2.3 Breakdown of primaries
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
FIGURE 4 MINIMALLY INVASIVE SURGERY MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
2.3.1.2 Approach 2: Customer-based market estimation
FIGURE 5 MINIMALLY INVASIVE SURGERY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.3.1.3 Approach 3: Top-down approach
2.3.1.4 Approach 4: Primary interviews
FIGURE 6 TOP-DOWN APPROACH
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH LIMITATIONS
2.6 STUDY ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT ANALYSIS
2.8 GROWTH RATE ASSUMPTIONS
2.9 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 8 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 9 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 10 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 11 GEOGRAPHIC SNAPSHOT OF MINIMALLY INVASIVE SURGERY MARKET
4 PREMIUM INSIGHTS
4.1 MINIMALLY INVASIVE SURGERY MARKET OVERVIEW
FIGURE 12 INCREASING ADOPTION OF MIS OVER OPEN SURGERIES TO DRIVE MARKET DURING FORECAST PERIOD
4.2 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
FIGURE 13 NORTH AMERICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.3 MINIMALLY INVASIVE SURGERY MARKET, BY REGION AND END USER, 2023 (USD MILLION)
FIGURE 14 HOSPITALS, CLINICS, AND ABLATION CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
4.4 GEOGRAPHIC SNAPSHOT OF MINIMALLY INVASIVE SURGERY MARKET
FIGURE 15 FRANCE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
FIGURE 16 MINIMALLY INVASIVE SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 Increasing number of hospitals and surgeries
5.1.1.2 Increasing adoption of MIS over open surgeries
5.1.1.3 Advantages of robot-assisted surgery & training in rehabilitation therapy
5.1.1.4 Technological advancements
TABLE 2 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL ROBOTS
5.1.2 RESTRAINTS
5.1.2.1 Changing regulatory landscape in medical devices
5.1.2.2 High cost of robotic systems
5.1.3 OPPORTUNITIES
5.1.3.1 Emerging markets
5.1.3.2 Increasing adoption of advanced robotics in ASCs
5.1.4 CHALLENGES
5.1.4.1 High degree of market consolidation
5.2 PORTER’S FIVE FORCES ANALYSIS
TABLE 3 MINIMALLY INVASIVE SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 THREAT OF SUBSTITUTES
5.2.3 BARGAINING POWER OF SUPPLIERS
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 DEGREE OF COMPETITION
5.3 TARIFF AND REGULATORY LANDSCAPE
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4 KEY REGULATORY GUIDELINES
5.4.1 US
TABLE 9 US FDA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.2 EUROPE
5.4.3 JAPAN
5.5 ECOSYSTEM ANALYSIS
FIGURE 17 MINIMALLY INVASIVE SURGERY MARKET: ECOSYSTEM
FIGURE 18 MINIMALLY INVASIVE SURGERY MARKET: KEY PLAYERS
5.6 TECHNOLOGY ANALYSIS
5.6.1 KEY TECHNOLOGIES
5.6.1.1 Laparoscopy
5.6.1.2 Ablation
5.6.1.3 Electrosurgery
5.6.1.4 Powered surgical products
5.6.2 COMPLIMENTARY TECHNOLOGIES
5.6.2.1 Robotic surgery
5.6.2.2 Digital solutions (AI, IoT)
5.6.2.3 Medical/Surgical imaging
5.6.3 ADJACENT TECHNOLOGIES
5.6.3.1 Endoscopes
5.6.3.2 Surgical implants
5.7 VALUE CHAIN ANALYSIS
5.7.1 RESEARCH & DEVELOPMENT
5.7.2 PROCUREMENT & PRODUCT DEVELOPMENT
5.7.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
FIGURE 19 MINIMALLY INVASIVE SURGERY MARKET: VALUE CHAIN ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
5.8.1 PROMINENT COMPANIES
5.8.2 SMALL & MEDIUM-SIZED COMPANIES
5.8.3 END USERS
FIGURE 20 MINIMALLY INVASIVE SURGERY MARKET: SUPPLY CHAIN ANALYSIS
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
5.9.2 KEY BUYING CRITERIA
5.10 REIMBURSEMENT SCENARIO
TABLE 11 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
5.11 PRICING ANALYSIS
FIGURE 21 AVERAGE SELLING PRICE OF MINIMALLY INVASIVE PRODUCTS, BY PRODUCT (FY 2021-2023)
FIGURE 22 AVERAGE SELLING PRICE TREND, BY REGION
5.12 PATENT ANALYSIS
FIGURE 23 PATENT DETAILS FOR MINIMALLY INVASIVE SURGERY DEVICES (JANUARY 2013–DECEMBER 2023)
5.13 TRADE ANALYSIS
TABLE 12 IMPORT DATA FOR MIS MARKET (HS CODE 9021), BY COUNTRY, 2018–2022 (USD THOUSAND)
TABLE 13 EXPORT DATA FOR MIS MARKET (HS CODE 3822), BY COUNTRY, 2018–2022 (USD THOUSAND)
5.14 CASE STUDIES
TABLE 14 CASE STUDY 1: ROLE OF MINIMALLY INVASIVE ROBOT-ASSISTED SURGERY IN UROLOGY
TABLE 15 CASE STUDY 2: PIONEERING ROBOT-ASSISTED LATERAL LUMBAR INTERBODY FUSION (LLIF) WITH EXCELSIUSGPS
5.15 KEY CONFERENCES AND EVENTS, 2023–2024
TABLE 16 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2023–2024
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 24 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
5.17 MINIMALLY INVASIVE SURGERY MARKET: RECESSION IMPACT
5.18 UNMET CUSTOMER NEEDS IN MINIMALLY INVASIVE SURGERY MARKET
5.19 INVESTMENT SCENARIO
FIGURE 25 NUMBER OF INVESTOR DEALS IN MINIMALLY INVASIVE SURGERY MARKET, BY KEY PLAYER, 2018–2022
FIGURE 26 VALUE OF INVESTOR DEALS IN MINIMALLY INVASIVE SURGERY MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
6 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 17 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
6.2 SURGICAL DEVICES
TABLE 18 SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 19 SURGICAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.1 HANDHELD INSTRUMENTS
TABLE 20 HANDHELD INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.1.1 Tubular retractors
6.2.1.1.1 Minimized tissue trauma and better outcomes to support adoption
6.2.1.2 Dilators
6.2.1.2.1 Safety and efficient surgical site access to support adoption
6.2.1.3 Suturing instruments
6.2.1.3.1 Rising procedural volume and growing demand for MIS to drive market
6.2.1.4 Probes
6.2.1.4.1 Advancements in instrumentation and product launches to drive market
6.2.1.5 Laser fiber devices
6.2.1.5.1 Growing demand in urology, gastroenterology, and other specialties to support market growth
6.2.2 GUIDING DEVICES
TABLE 21 GUIDING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.2.1 Guiding catheters
6.2.2.1.1 Focus on functional and design improvements to drive demand
6.2.2.2 Guidewires
6.2.2.2.1 Rising PCTA and PTA procedural volumes to ensure demand growth
6.2.3 INFLATION SYSTEMS
TABLE 22 INFLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.3.1 Balloon catheters
6.2.3.1.1 Technological advancements in balloon systems to support growth
6.2.3.2 Balloon inflation systems
6.2.3.2.1 Growing adoption of MIS in coronary and peripheral disease treatment to drive market
6.2.4 LAPAROSCOPY DEVICES
TABLE 23 LAPAROSCOPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.4.1 Laparoscopes
6.2.4.1.1 Lower risk of laparoscopic procedures to drive demand
6.2.4.2 Trocars & cannulas
6.2.4.2.1 Need to ensure accurate placement to support growth
6.2.4.3 Graspers & dissectors
6.2.4.3.1 Benefits such as increased safety and better reach to drive adoption
6.3 IMAGING & VISUALIZATION SYSTEMS
TABLE 24 IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 25 IMAGING & VISUALIZATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.1 ULTRASOUND SYSTEMS
6.3.1.1 Ultrasound to hold largest share of imaging & visualization systems market
TABLE 26 ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.2 CT SCANNERS
6.3.2.1 Shift toward image-guided interventions and rising disease prevalence to drive market
TABLE 27 CT SCANNERS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.3 MRI SYSTEMS
6.3.3.1 Wide usage and technological advancements to support growth
TABLE 28 MRI SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.4 X-RAY SYSTEMS
6.3.4.1 Rising emphasis on digital X-ray systems to drive market
TABLE 29 X-RAY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.5 VISUALIZATION SYSTEMS
6.3.5.1 High levels of detail and better outcomes to drive demand
TABLE 30 VISUALIZATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4 ELECTROSURGICAL DEVICES
TABLE 31 ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 32 ELECTROSURGICAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4.1 ELECTROCAUTERY DEVICES
6.4.1.1 Increasing plastic surgeries to drive market
TABLE 33 ELECTROCAUTERY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4.2 ELECTROSURGICAL GENERATORS & ACCESSORIES
6.4.2.1 Growing use of disposables and reusable instruments to drive market
TABLE 34 ELECTROSURGICAL GENERATORS & ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.5 ENDOSCOPY DEVICES
TABLE 35 ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 36 ENDOSCOPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.5.1 RIGID ENDOSCOPES
6.5.1.1 Rigid endoscopes to hold largest market share
TABLE 37 RIGID ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.5.2 FLEXIBLE ENDOSCOPES
6.5.2.1 Rising incidence of cancer to drive demand
TABLE 38 FLEXIBLE ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.5.3 DIAGNOSTIC ENDOSCOPES
6.5.3.1 Role of diagnostic endoscopes to expand due to versatility and sophistication
TABLE 39 DIAGNOSTIC ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.6 MEDICAL ROBOTICS
TABLE 40 MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 41 MEDICAL ROBOTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.6.1 ROBOTIC SYSTEMS
6.6.1.1 Accuracy, efficiency, and ability to conduct highly complex procedures to support market growth
TABLE 42 ROB0TIC SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.6.2 ROBOTIC INSTRUMENTS
6.6.2.1 Rising demand for robotic surgical procedures to drive market
TABLE 43 ROB0TIC INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.6.3 ROBOTIC SOFTWARE & SERVICES
6.6.3.1 Need for basic training and expertise in robotic systems to drive market
TABLE 44 ROBOTIC SOFTWARE & SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
7 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 45 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
7.2 CARDIOTHORACIC SURGERY
7.2.1 GROWING BURDEN OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
TABLE 46 MINIMALLY INVASIVE SURGERY MARKET FOR CARDIOTHORACIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.3 VASCULAR SURGERY
7.3.1 BENEFITS SUCH AS PRECISE CUTS WITH LIMITED BLOOD LOSS IN VASCULAR SURGERY TO SUPPORT GROWTH
TABLE 47 MINIMALLY INVASIVE SURGERY MARKET FOR VASCULAR SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.4 NEUROLOGICAL SURGERY
7.4.1 INCREASING NUMBER OF PATIENTS SUFFERING FROM NEUROLOGICAL DISORDERS TO DRIVE SEGMENT GROWTH
TABLE 48 MINIMALLY INVASIVE SURGERY MARKET FOR NEUROLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.5 ENT & RESPIRATORY SURGERY
7.5.1 BENEFITS OF MIS IN HEAD AND NECK DISORDER TREATMENT TO DRIVE MARKET
TABLE 49 MINIMALLY INVASIVE SURGERY MARKET FOR ENT & RESPIRATORY SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.6 COSMETIC SURGERY
7.6.1 GROWING PREFERENCE FOR COSMETIC PROCEDURES TO DRIVE MARKET
TABLE 50 MINIMALLY INVASIVE SURGERY MARKET FOR COSMETIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.7 GASTROINTESTINAL & ABDOMINAL SURGERY
7.7.1 RISING COLORECTAL CANCER PREVALENCE TO SUPPORT DEMAND
TABLE 51 MINIMALLY INVASIVE SURGERY MARKET FOR GASTROINTESTINAL & ABDOMINAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.8 GYNECOLOGICAL SURGERY
7.8.1 GROWING NUMBER OF LAPAROSCOPIC HYSTERECTOMIES PERFORMED TO SUPPORT MARKET GROWTH
TABLE 52 MINIMALLY INVASIVE SURGERY MARKET FOR GYNECOLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.9 UROLOGICAL SURGERY
7.9.1 INCREASING PREVALENCE OF UROLOGIC CANCERS TO DRIVE ADOPTION OF MIS
TABLE 53 MINIMALLY INVASIVE SURGERY MARKET FOR UROLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.10 ORTHOPEDIC SURGERY
7.10.1 RISING GERIATRIC POPULATION AND INCREASE IN ORTHOPEDIC DISORDERS TO DRIVE MARKET
TABLE 54 MINIMALLY INVASIVE SURGERY MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.11 ONCOLOGICAL SURGERY
7.11.1 GROWING DEMAND FOR RADIOTHERAPY AND CHEMOTHERAPY TO AFFECT SEGMENT GROWTH
TABLE 55 MINIMALLY INVASIVE SURGERY MARKET FOR ONCOLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.12 DENTAL SURGERY
7.12.1 EMPHASIS ON PREVENTIVE DENTAL CARE TO SUPPORT MARKET GROWTH
TABLE 56 MINIMALLY INVASIVE SURGERY MARKET FOR DENTAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
7.13 OTHER SURGERIES
TABLE 57 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER SURGERIES, BY REGION, 2022–2029 (USD MILLION)
8 MINIMALLY INVASIVE SURGERY MARKET, BY END USER
8.1 INTRODUCTION
TABLE 58 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
8.2 HOSPITALS, CLINICS, AND ABLATION CENTERS
8.2.1 RISING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE MARKET
TABLE 59 MINIMALLY INVASIVE SURGERY MARKET FOR HOSPITALS, CLINICS AND ABLATION CENTERS, BY REGION, 2022–2029 (USD MILLION)
8.3 AMBULATORY SURGERY CENTERS
8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL GROWTH
TABLE 60 MINIMALLY INVASIVE SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION)
8.4 ORTHOPEDIC, EMERGENCY, AND TRAUMA CENTERS
8.4.1 RISING USE OF ROBOTIC-ASSISTED SURGICAL SYSTEMS IN ORTHOPEDICS, EMERGENCY, AND TRAUMA CARE TO SUPPORT GROWTH
TABLE 61 MINIMALLY INVASIVE SURGERY MARKET FOR ORTHOPEDIC, EMERGENCY, AND TRAUMA CENTERS, BY REGION, 2022–2029 (USD MILLION)
8.5 OTHER END USERS
TABLE 62 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
9 MINIMALLY INVASIVE SURGERY MARKET, BY REGION
9.1 INTRODUCTION
TABLE 63 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2022–2029 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 27 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT
TABLE 64 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 66 NORTH AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 67 NORTH AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 68 NORTH AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 69 NORTH AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 70 NORTH AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 71 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 72 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2.2 US
9.2.2.1 US to dominate North American market
TABLE 73 US: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 74 US: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 75 US: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 76 US: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 77 US: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 78 US: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Rising cancer and IBD incidence to drive market
TABLE 79 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 80 CANADA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 81 CANADA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 82 CANADA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 83 CANADA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 84 CANADA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
TABLE 85 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 87 EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 88 EUROPE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 89 EUROPE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 90 EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 91 EUROPE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 92 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 93 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Well-established healthcare system in Germany to boost usage of instruments
TABLE 94 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 95 GERMANY: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 96 GERMANY: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 97 GERMANY: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 98 GERMANY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 99 GERMANY: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Rising number of hip & knee surgeries to drive market
TABLE 100 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 101 FRANCE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 102 FRANCE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 103 FRANCE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 104 FRANCE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 105 FRANCE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.3.4 UK
9.3.4.1 High incidence of cancer in the UK to boost adoption of MIS instruments
TABLE 106 UK: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 107 UK: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 108 UK: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 109 UK: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 110 UK: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 111 UK: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Demand for MIS to positively affect market growth
TABLE 112 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 113 ITALY: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 114 ITALY: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 115 ITALY: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 116 ITALY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 117 ITALY: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Increasing incidence of CVD to boost adoption of MIS and drive market growth
TABLE 118 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 119 SPAIN: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 120 SPAIN: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 121 SPAIN: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 122 SPAIN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 123 SPAIN: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 124 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 125 REST OF EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 126 REST OF EUROPE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 127 REST OF EUROPE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 128 REST OF EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 129 REST OF EUROPE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 28 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT
TABLE 130 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 131 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 132 ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 133 ASIA PACIFIC: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 134 ASIA PACIFIC: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 135 ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 136 ASIA PACIFIC: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 137 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 138 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising geriatric population in Japan to increase prevalence of chronic conditions and support market growth
TABLE 139 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 140 JAPAN: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 141 JAPAN: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 142 JAPAN: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 143 JAPAN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 144 JAPAN: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.4.3 CHINA
9.4.3.1 Rising disease prevalence and infrastructural improvements to support market growth
TABLE 145 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 146 CHINA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 147 CHINA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 148 CHINA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 149 CHINA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 150 CHINA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Healthcare infrastructure improvements and increasing geriatric population to drive market
TABLE 151 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 152 INDIA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 153 INDIA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 154 INDIA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 155 INDIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 156 INDIA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.4.5 AUSTRALIA
9.4.5.1 Uneven distribution of specialists to hinder market growth
TABLE 157 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 158 AUSTRALIA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 159 AUSTRALIA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 160 AUSTRALIA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 161 AUSTRALIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 162 AUSTRALIA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.4.6 SOUTH KOREA
9.4.6.1 Growing medical tourism to favor demand for MIS
TABLE 163 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 164 SOUTH KOREA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 165 SOUTH KOREA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 166 SOUTH KOREA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 167 SOUTH KOREA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 168 SOUTH KOREA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 169 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 170 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 171 REST OF ASIA PACIFIC: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 172 REST OF ASIA PACIFIC: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 173 REST OF ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 174 REST OF ASIA PACIFIC: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 175 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 177 LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 178 LATIN AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 179 LATIN AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 180 LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 181 LATIN AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 182 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 183 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
9.5.2 BRAZIL
9.5.2.1 Favorable healthcare policies by government and private organizations to propel market growth
TABLE 184 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 185 BRAZIL: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 186 BRAZIL: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 187 BRAZIL: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 188 BRAZIL: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 189 BRAZIL: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.5.3 MEXICO
9.5.3.1 Rising adoption of robotics in cosmetic surgeries to drive market
TABLE 190 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 191 MEXICO: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 192 MEXICO: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 193 MEXICO: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 194 MEXICO: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 195 MEXICO: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
TABLE 196 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 197 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 198 REST OF LATIN AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 199 REST OF LATIN AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 200 REST OF LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 201 REST OF LATIN AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 202 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 203 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 204 MIDDLE EAST & AFRICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 205 MIDDLE EAST & AFRICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 206 MIDDLE EAST & AFRICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 207 MIDDLE EAST & AFRICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 208 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 209 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION)
9.6.2 GCC COUNTRIES
9.6.2.1 Growing demand for minimally invasive procedures
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 29 OVERVIEW OF STRATEGIES ADOPTED BY MINIMALLY INVASIVE SURGERY PLAYERS
10.3 REVENUE SHARE ANALYSIS
FIGURE 30 REVENUE SHARE ANALYSIS FOR KEY PLAYERS, 2018–2022 (USD MILLION)
10.4 MARKET SHARE ANALYSIS
10.4.1 GLOBAL SURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 31 SURGICAL DEVICES MARKET SHARE ANALYSIS, 2022
10.4.2 GLOBAL IMAGING & VISUALIZATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 32 IMAGING & VISUALIZATION SYSTEMS MARKET SHARE ANALYSIS, 2022
10.4.3 GLOBAL ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 33 ENDOSCOPY DEVICES MARKET SHARE ANALYSIS, 2022
10.4.4 GLOBAL ELECTROSURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 34 ELECTROSURGICAL DEVICES MARKET SHARE ANALYSIS, 2022
10.4.5 GLOBAL MEDICAL ROBOTICS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 35 MEDICAL ROBOTICS MARKET SHARE ANALYSIS, 2022
FIGURE 36 MINIMALLY INVASIVE SURGERY MARKET SHARE, BY PLAYER (2023)
TABLE 210 MINIMALLY INVASIVE SURGERY MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION MATRIX (KEY PLAYERS)
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 37 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
10.5.5 COMPANY FOOTPRINT
FIGURE 38 COMPANY FOOTPRINT (15 COMPANIES)
TABLE 211 PRODUCT FOOTPRINT (15 COMPANIES)
TABLE 212 REGIONAL FOOTPRINT (15 COMPANIES)
TABLE 213 APPLICATION FOOTPRINT (15 COMPANIES)
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 39 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022
10.6.5 COMPANY BENCHMARKING
TABLE 214 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY EMERGING PLAYERS/STARTUPS
TABLE 215 MINIMALLY INVASIVE SURGERY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 216 MINIMALLY INVASIVE SURGERY MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2021—OCTOBER 2023)
10.7.2 DEALS
TABLE 217 MINIMALLY INVASIVE SURGERY MARKET: DEALS (JANUARY 2021—OCTOBER 2023)
10.8 COMPANY VALUATION AND FINANCIAL METRICS
FIGURE 40 EV/EBITDA OF KEY VENDORS
FIGURE 41 5-YEAR STOCK BETA OF KEY VENDORS
10.9 PRODUCT/BRAND COMPARISON
FIGURE 42 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL (2023)
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 MEDTRONIC PLC
TABLE 218 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
TABLE 219 MEDTRONIC PLC: PRODUCTS OFFERED
TABLE 220 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 221 MEDTRONIC PLC: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.2 JOHNSON & JOHNSON MEDTECH
TABLE 222 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW
FIGURE 44 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2022)
TABLE 223 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED
TABLE 224 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 225 JOHNSON & JOHNSON: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.3 STRYKER CORPORATION
TABLE 226 STRYKER CORPORATION: COMPANY OVERVIEW
FIGURE 45 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 227 STRYKER CORPORATION: PRODUCTS OFFERED
TABLE 228 STRYKER CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 229 STRYKER CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.4 BOSTON SCIENTIFIC CORPORATION
TABLE 230 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 231 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 232 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 233 BOSTON SCIENTIFIC CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.5 ABBOTT LABORATORIES
TABLE 234 ABBOTT LABORATORIES: COMPANY OVERVIEW
FIGURE 47 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
TABLE 235 ABBOTT LABORATORIES: PRODUCTS OFFERED
TABLE 236 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
11.1.6 ZIMMER BIOMET HOLDINGS, INC.
TABLE 237 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW
FIGURE 48 ZIMMER BIOMET HOLDINGS: COMPANY SNAPSHOT (2022)
TABLE 238 ZIMMER BIOMET HOLDINGS: PRODUCTS OFFERED
TABLE 239 ZIMMER BIOMET HOLDINGS: PRODUCT APPROVALS (JANUARY 2020–DECEMBER 2023)
11.1.7 B. BRAUN MELSUNGEN AG
TABLE 240 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
FIGURE 49 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
TABLE 241 B. BRAUN MELSUNGEN: PRODUCTS OFFERED
11.1.8 NUVASIVE, INC.
TABLE 242 NUVASIVE, INC: COMPANY OVERVIEW
FIGURE 50 NUVASIVE, INC: COMPANY SNAPSHOT (2022)
TABLE 243 NUVASIVE INC.: PRODUCTS OFFERED
TABLE 244 NUVASIVE, INC: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 245 NUVASIVE INC.: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.9 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 246 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW
FIGURE 51 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 247 INTEGRA LIFESCIENCES HOLDING CORPORATION: PRODUCTS OFFERED
11.1.10 ATEC SPINE
TABLE 248 ATEC SPINE: COMPANY OVERVIEW
FIGURE 52 ATEC SPINE: COMPANY SNAPSHOT (2022)
TABLE 249 ATEC SPINE: PRODUCTS OFFERED
11.1.11 SIEMENS HEALTHINEERS AG
TABLE 250 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
FIGURE 53 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
TABLE 251 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
TABLE 252 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 253 SIEMENS HEALTHINEERS AG: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 254 SIEMENS HEALTHINEERS AG: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
11.1.12 COOK MEDICAL
TABLE 255 COOK MEDICAL: COMPANY OVERVIEW
TABLE 256 COOK MEDICAL: PRODUCTS OFFERED
11.1.13 FUJIFILM CORPORATION
TABLE 257 FUJIFILM CORPORATION: COMPANY OVERVIEW
FIGURE 54 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 258 FUJIFILM CORPORATION: PRODUCTS OFFERED
TABLE 259 FUJIFILM CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 260 FUJIFILM CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 261 FUJIFILM CORPORATION: EXPANSION (JANUARY 2020–DECEMBER 2023)
TABLE 262 FUJIFILM CORPORATION: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
11.1.14 BECTON, DICKINSON AND COMPANY
TABLE 263 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
TABLE 264 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 265 BECTON, DICKINSON AND COMPANY: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 266 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
11.1.15 PHILIPS HEALTHCARE
TABLE 267 PHILIPS HEALTHCARE: COMPANY OVERVIEW
FIGURE 56 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)
TABLE 268 PHILIPS HEALTHCARE: PRODUCTS OFFERED
TABLE 269 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 270 PHILIPS HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023)
11.1.16 GLOBUS MEDICAL, INC.
TABLE 271 GLOBUS MEDICAL, INC.: COMPANY OVERVIEW
FIGURE 57 GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT (2022)
TABLE 272 GLOBUS MEDICAL: PRODUCTS OFFERED
TABLE 273 GLOBUS MEDICAL: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
11.2 OTHER PLAYERS
11.2.1 INTUITIVE SURGICAL INC.
TABLE 274 INTUITIVE SURGICAL INC.: COMPANY OVERVIEW
FIGURE 58 INTUITIVE SURGICAL INC.: COMPANY SNAPSHOT (2022)
TABLE 275 INTUITIVE SURGICAL INC.: PRODUCTS OFFERED
TABLE 276 INTUITIVE SURGICAL, INC.: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 277 INTUITIVE SURGICAL, INC.: DEALS (JANUARY 2020–DECEMBER 2023)
11.2.2 KARL STORZ
TABLE 278 KARL STORZ: COMPANY OVERVIEW (2022)
TABLE 279 KARL STORZ: PRODUCTS OFFERED
TABLE 280 KARL STORZ: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 281 KARL STORZ: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
11.2.3 EDWARDS LIFESCIENCES CORPORATION
TABLE 282 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
FIGURE 59 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 283 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
11.2.4 SMITH+NEPHEW
TABLE 284 SMITH+NEPHEW: COMPANY OVERVIEW
FIGURE 60 SMITH+NEPHEW: COMPANY SNAPSHOT (2022)
TABLE 285 SMITH+NEPHEW: PRODUCTS OFFERED
TABLE 286 SMITH+NEPHEW: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 287 SMITH+ NEPHEW: DEALS (JANUARY 2020–DECEMBER 2023)
11.2.5 GE HEALTHCARE
TABLE 288 GE HEALTHCARE: COMPANY OVERVIEW
FIGURE 61 GENERAL ELECTRIC: COMPANY SNAPSHOT (2022)
TABLE 289 GE HEALTHCARE: PRODUCTS OFFERED
TABLE 290 GE HEALTHCARE: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 291 GE HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 292 NIPRO CORPORATION: COMPANY OVERVIEW
FIGURE 62 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 293 NIPRO CORPORATION: PRODUCTS OFFERED
TABLE 294 NIPRO CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023)
11.2.7 GETINGE AB
TABLE 295 GETINGE AB: COMPANY OVERVIEW
FIGURE 63 GETINGE AB: COMPANY SNAPSHOT (2022)
TABLE 296 GETINGE AB: PRODUCTS OFFERED
11.2.8 CONMED CORPORATION
TABLE 297 CONMED CORPORATION: COMPANY OVERVIEW
FIGURE 64 CONMED CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 298 CONMED CORPORATION: PRODUCTS OFFERED
TABLE 299 CONMED CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
11.2.9 TELEFLEX INCORPORATED
TABLE 300 TELEFLEX INCORPORATED: COMPANY OVERVIEW
FIGURE 65 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
TABLE 301 TELEFLEX INCORPORATED: PRODUCTS OFFERED
TABLE 302 TELEFLEX INCORPORATION: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
11.2.10 ACCURAY
TABLE 303 ACCURAY: COMPANY OVERVIEW
FIGURE 66 ACCURAY: COMPANY SNAPSHOT (2022)
TABLE 304 ACCURAY: PRODUCTS OFFERED
TABLE 305 ACCURAY: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 306 ACCURAY: DEALS (JANUARY 2020–DECEMBER 2023)
11.2.11 OLYMPUS CORPORATION
TABLE 307 OLYMPUS CORPORATION: COMPANY OVERVIEW
FIGURE 67 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 308 OLYMPUS CORPORATION: PRODUCTS OFFERED
TABLE 309 OLYMPUS CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 310 OLYMPUS CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2.12 MASIMO
11.2.13 COOPERSURGICAL INC.
11.2.14 APPLIED MEDICAL
11.2.15 RICHARD WOLF
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
